Tandem Diabetes Care Inc (FRA:TD5A)
€ 46.5 -0.61 (-1.29%) Market Cap: 3.09 Bil Enterprise Value: 3.10 Bil PE Ratio: 0 PB Ratio: 13.74 GF Score: 78/100

Tandem Diabetes Care Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) Transcript

Sep 21, 2020 / 03:40PM GMT
Release Date Price: €89.43 (-0.62%)
Steven Michael Lichtman
Oppenheimer & Co. Inc., Research Division - MD and Senior Analyst

Hello, everyone. Welcome back to the Oppenheimer Life Sciences and MedTech Summit. My name is Steve Lichtman, Senior Medical Devices analyst here at Oppenheimer. Very happy to have with us up next Tandem Diabetes Care. With us today is John Sheridan, President and CEO; Susan Morrison, EVP and CAO; and Ms. Gasser, EVP, Strategy and Corporate Development.

I'm going to turn the podium briefly over to John, who's going to have a couple of remarks to kick us off. And then we're going to do a fireside chat format, which I'll lead the Q&A. And if you have any questions, please submit them through the link that was sent to you, and I'll get them right over to management.

And with that, I'm going to turn it over to John.

John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director

Thanks, Steve. It's really nice to be here today. I'd just like to start off by reminding people of where we came from. And that is that Tandem from the very

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot